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Introduction: Online media may influence women’s decision to undergo vaccination during pregnancy.
The aims of this mixed-methods study were to: (1) examine the portrayal of maternal vaccination in
online media and (2) establish the perceived target of vaccine protection as viewed by pregnant women
and maternity healthcare professionals (HCPs).
Methods: Online media articles on maternal vaccination (published July-December 2012 or November
2015-April 2016) were identified through the London School of Hygiene & Tropical Medicine’s Vaccine
Confidence Database and thematically analysed. Questionnaires for pregnant women and HCPs were
distributed within four English hospitals (July 2017-January 2018).
Results: Of 203 articles identified, 60% related to pertussis vaccination, 33% to influenza and 6% both. The
majority positively portrayed vaccination in pregnancy (97%), but inaccurate, negative articles persist
which criticize pertussis vaccination’s safety and efficacy. Positively-worded articles about pertussis
tended to focus on infant protection and highlight examples of recent cases, whereas positively-
worded articles about influenza focused on maternal protection. These themes were reflected in ques-
tionnaire responses from 314 pregnant women and 204 HCPs, who perceived pertussis vaccination as
protecting the baby, and influenza vaccination as protecting the mother, or mother and baby equally.
A minority of the pregnant women surveyed intended to decline influenza (22%) or pertussis (8%) vacci-
nation.
Conclusions: The majority of online articles support pertussis and influenza vaccination during preg-
nancy. The portrayal of pertussis vaccination as primarily benefiting the child, using real-examples,
may influence its higher uptake compared with influenza. This approach should be considered by
HCPs when recommending vaccination. HCPs should be prepared to provide advice to women hesitant
about vaccination, including addressing any negative media, and consider educational strategies to coun-
teract inaccurate information. Future studies should directly assess the influence of media on vaccine
decision-making and establish which media platforms are typically used by pregnant women to gather
information.
 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Vaccination in pregnancy is a safe and effective strategy to pro-
tect mothers and young infants from infectious disease at a time
when they are particularly vulnerable [1–4]. A number of vaccines
are now routinely offered to pregnant women, including pertussis,
influenza and tetanus [5]. Infection with pertussis or influenza can
7626 C.R Wilcox et al. / Vaccine 36 (2018) 7625–7631result in adverse events for mother, fetus and infant, including sev-
ere respiratory illness and death [6–7].
Vaccine availability is not a guarantee of vaccine uptake, partic-
ularly amongst pregnant women. International campaigns for vac-
cination have been met with differing levels of acceptance
depending on their perceived need and efficacy, as well as safety
[8–9], influencing vaccine confidence [10]. In England, from
September 2016 to January 2017 the uptake of influenza vaccina-
tion in pregnancy was only 44.9% [11] whilst the uptake of pertus-
sis vaccination was 74.2% [12], however rates vary significantly
across different areas of the UK [13], and between different coun-
tries [10].
Vaccine confidence is an increasingly important public health
issue. The World Health Organization (WHO) Strategic Advisory
Group of Experts (SAGE) on immunisation, as well as various
national health bodies, have called for improved monitoring of vac-
cine confidence and further research into the socio-economic
determinants of vaccine attitudes [14]. The exponential increase
in health-related online resources has also had a significant effect
on how patients seek health information globally [15] and can sig-
nificantly influence patients’ vaccine confidence and decision-
making [13].
The aims of this mixed-methods study were therefore: (1) to
examine the portrayal of maternal influenza and pertussis vaccina-
tion in online media over recent years and consider what influence
this may have had on women’s vaccine confidence, and (2) to com-
pare these findings with the perceived target of vaccine protection
as viewed by maternity healthcare professional’s (HCPs) and preg-
nant women, as well as their reported current, or intended, uptake
of vaccination.2. Methods
2.1. Identification of online media articles and thematic analysis
A search was conducted in the Vaccine Confidence Project’s
database at the London School of Hygiene & Tropical Medicine,
using the keyword ‘‘pregnan*”. This database collects online news
articles relating to vaccination (published from any country), as
part of a surveillance system to monitor public confidence in
vaccination (www.vaccineconfidence.org). News articles were
deemed eligible if they related to influenza or pertussis vaccination
in pregnancy, and were published in the English language during
two different time periods: July to December 2012, or November
2015 to April 2016. Choosing two time periods allowed us to com-
pare how the occurrence of articles on each vaccination, and the
media themes within these, had changed over time. The 2012 per-
iod was selected as it was during this time that the pertussis vac-
cine was first routinely introduced for pregnant women in the UK,
and the 2015 to 2016 period was the most recent six months of
data available to us at the time of the search, and closest to the
time when we distributed the questionnaire. The full text was
screened of any article considered potentially relevant following
the keyword search, and those deemed eligible for inclusion were
then coded by theme, and thematically analysed [16]. Coding was
conducted by a single author to ensure consistency (KB).2.2. Questionnaire design and development
Two separate questionnaires were developed for pregnant
women and maternity HCPs. These were developed with multi-
disciplinary input from paediatricians, obstetricians and health
psychologists. The questions analysed here were nested within a
larger questionnaire focussing on the attitudes of pregnant women
and HCPs to both routine vaccination in pregnancy, and to clinicaltrials of vaccines in pregnancy against respiratory syncytial virus
(RSV). The current paper focuses only on the questions related to
routinely recommended vaccines (see Supplementary file). Preg-
nant women were asked whether they had received/were planning
to receive influenza and pertussis vaccination, and both pregnant
women and HCPs were asked for their opinion as to whether the
influenza and pertussis vaccines were given to primarily protect
the mother, the baby, or both equally. The study was registered
on ClinicalTrials.gov (NCT03096574) and ethical approval was
granted (reference 17/LO/0537) prior to recruitment commencing.2.3. Study population and recruitment
The questionnaire for pregnant women was administered to
women (aged  16 years) attending routine pregnancy clinics/
wards at four study sites: University Hospital Southampton NHS
Foundation Trust, St Georges Healthcare NHS Trust, University
Hospitals Bristol NHS Foundation Trust, and Oxford University
Hospitals NHS Foundation Trust. The HCP questionnaire was
administered to midwives or obstetricians at the same four sites.
Recruitment took place between July 2017–January 2018. Pregnant
women were recruited in person via opportunistic sampling. HCPs
were invited to participate by an email containing a link to an
online questionnaire, supported by face-to-face invitations. Partic-
ipants gave informed consent and questionnaires contained no
identifiable information.2.4. Questionnaire data analysis
Data from paper questionnaires were entered at the lead site
into iSurvey (www.isurvey.soton.ac.uk). Statistical analysis was
performed using GraphPad QuickCalcs (https://www.graph-
pad.com/quickcalcs). A two-tailed Fisher’s exact test was used to
compare frequency of themes in articles. P-values < 0.05 were con-
sidered as statistically significant.3. Results
3.1. Overview of online media articles
In total, 203 media articles were identified, with 123 articles
(61%) originating from the July to December 2012 time period
and 80 articles (39%) from the November 2015 to April 2016 time
period. Out of the total number of articles, 122 (60%) concerned
pertussis vaccination only, 68 (33%) concerned influenza vaccina-
tion only, and 13 (6%) concerned both. During 2012, 84/123
(68%) concerned pertussis, 34 (28%) concerned influenza, and five
(4%) concerned both. During 2015–2016, 38 (48%) concerned per-
tussis, 34 (43%) concerned influenza, and eight (10%) concerned
both. The majority of the articles were published in the UK (60%),
followed by the USA (22%), Australia (8%), Canada (2%), India
(2%), New Zealand (2%), Spain (2%), Holland (1%) and South Africa
(1%).3.2. Thematic analysis of online media articles
Articles were analysed and 12 themes (10 positive and two neg-
ative) were identified (Table 1). Themes were deemed to be ‘posi-
tive’ if they were associated with encouraging vaccine use, and
‘negative’ if they were associated with discouraging vaccine use.
The overwhelming majority of articles contained positive informa-
tion, with only seven (3%) containing negative themes, all of which
were regarding pertussis vaccination. Figs. 1 and 2 display the
themes identified across the articles relating to the influenza and
Fig. 1. Occurrence of themes in articles regarding influenza and pertussis vaccination in pregnancy between July and December 2012.
Table 1
Themes identified in online media articles relating to influenza and pertussis vaccination in pregnancy, 2012 and 2015–2016.
Themes Frequency in 2012
influenza articles (N = 34)
Frequency in 2012
pertussis articles (N = 84)
Frequency in 2015–2016
influenza articles (N = 34)
Frequency in 2015–2016
pertussis articles (N = 38)
Protecting self 16 (47%) ** 0 (0%) ** 16 (47%) ** 0 (0%) **
Protecting fetus 6 (18%) ** 0 (0%) ** 9 (26%) ** 0 (0%) **
Protecting newborn 14 (41%) ** 67 (80%) ** 16 (47%) 14 (37%)
Protecting other infants 0 (0%) 1 (1%) 0 (0%) 0 (0%)
Recent infections in the area 0 (0%) ** 62 (74%) ** 6 (18%) ** 26 (68%) **
Mortality of the disease 1 (3%) 5 (6%) 2 (6%) 5 (13%)
Increased severity of disease 27 (79%) ** 34 (40%) ** 24 (71%) 19 (50%)
Vaccine safety (positive) 8 (24%) ** 3 (4%) ** 8 (24%) 3 (8%)
Vaccine safety (negative) 0 (0%) 1 (1%) 0 (0%) 3 (8%)
Vaccine efficacy (positive) 5 (15%) 5 (6%) 6 (18%) 5 (13%)
Vaccine efficacy (negative) 0 (0%) 3 (4%) 0 (0%) 3 (8%)
Lack of financial cost (positive) 9 (26%) ** 2 (2%) ** 6 (18%) 2 (5%)
Data are N (%).
*p < 0.05.
** p < 0.001.
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respectively.
A significantly higher proportion of articles about influenza vac-
cination in pregnancy contained the positive theme of ‘‘protecting
self” compared to those articles about pertussis vaccination in both
time periods. The positive theme of ‘‘protecting fetus” was also sig-
nificantly more common in influenza articles in both time periods.
In contrast, the positive theme of ‘‘protecting newborn” was signif-
icantly more common in online media articles about pertussis vac-
cination during 2012, but during 2015–2016 articles about
pertussis vaccination and those about influenza vaccination this
difference was no longer observed.
Another positive theme in terms of understanding the impor-
tance of the vaccine was ‘‘recent infections in the area”. A signifi-
cantly higher proportion of pertussis articles contained this
theme than influenza articles across both the 2012 period and
the 2015–2016 period. ‘‘Mortality of the disease” was mentioned
infrequently in articles about influenza and pertussis vaccination.‘‘Increased severity of disease for the mother”, however, was men-
tioned more often in influenza articles. The positive theme of ‘‘vac-
cine safety” was identified significantly more often in articles
about influenza vaccination compared to pertussis vaccination
(Table 1).
Finally, ‘‘lack of financial cost” was identified as a positive
theme in articles which discussed the availability of vaccines in
pregnancy being offered for free as part of routine care. This theme
was identified more commonly in articles about influenza vaccina-
tion compared to pertussis vaccination across both time periods.
‘‘Financial costs” was not identified as a negative theme in any
articles.
Seven of the 135 articles mentioning pertussis (5%) contained
negative themes. Three of these articles were from the 2012 period,
with two criticising the efficacy of the vaccine, and one criticising
both its efficacy and safety. Extracts from these articles include:
‘‘More damning evidence of the ineffectiveness of the pertussis
vaccine is evident in the current outbreak in Washington State.”
Fig. 2. Occurrence of themes in articles regarding influenza and pertussis vaccination in pregnancy between November 2015 and April 2016.
Table 2
Characteristics of the respondents to questionnaires (pregnant women and healthcare
professionals).
Characteristic Pregnant women,
N = 314
Healthcare professionals,
N = 204
Study site
A 88 (28%) 45 (22%)
B 77 (25%) 55 (27%)
C 79 (25%) 62 (30%)
D 70 (22%) 42 (21%)
Age (years)
16–24 34 (11%) –
25–30 107 (34%) –
31–35 92 (29%) –
36–40 58 (19%) –
41–45 13 (4%) –
Profession –
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hoped” and ‘‘The un-vaccinated people aren’t the people getting
whooping cough, it’s the ones who ARE vaccinated!”
‘‘The truth is that the Tdap shot has never been proven safe for
use during pregnancy.”
The remaining four of these articles containing negative themes
were from the 2015-2016 period. Three concerned the efficacy
of the vaccine, and one concerned its safety. Extracts from these
articles include:
‘‘Safety improved but period of protection is less - 6 years now
compared to 14 years.”
‘‘There are zero testing results for pregnant women. It has not
been demonstrated that the vaccines are safe for pregnancy.”
‘‘There is no evidence yet to support any level of infant immu-
nity from this.”Obstetrics – 37 (18%)
Midwifery – 153 (75%)
No response – 14 (7%)
Data are N (%).3.3. Questionnaire responses
A total of 321 pregnant women and 204 maternity HCPs
completed the questionnaires, across the four sites. Eight question-
naires from pregnant women were excluded due to largely incom-
plete or illegible responses, leaving 314 pregnant women (97.8%).
The characteristics of respondents, including demographic details,
are displayed in Table 2. Regarding influenza vaccination, of 310
responses from pregnant women, 118 (38%) had been vaccinated,
123 (40%) were intending to be vaccinated, and 69 (22%) were
not intending to receive vaccination. Regarding pertussis vaccina-
tion, of 302 responses, 168 (56%) had been vaccinated, 109 (36%)
were intending to be vaccinated, and 25 (8.3%) were not intending
to receive vaccination.
Both pregnant women and HCPs were also asked whether they
thought the influenza and pertussis vaccines were given to primar-
ily protect the mother, the baby, or both equally, see Table 3.
Regarding influenza vaccination, out of 300 responses from preg-
nant women, 58 (19%), 24 (8%) and 218 (73%) responded ‘‘the
mother”, ‘‘the baby” and ‘‘both equally”. Of 199 HCP responses,
101 (51%), 5 (3%) and 93 (47%) responded ‘‘the mother”, ‘‘the baby”and ‘‘both equally”, respectively. Regarding pertussis vaccination,
out of 303 pregnant women responses, 8 (3%), 172 (57%) and 123
(41%) responded ‘‘the mother”, ‘‘the baby”, and ‘‘both equally”,
respectively. Of 199 HCP responses, 4 (2%), 141 (71%) and 54
(27%) responded ‘‘the mother”, ‘‘the baby” and ‘‘both equally”,
respectively.4. Discussion
To our knowledge, this is the first study to thematically analyse
media articles relating specifically to vaccination in pregnancy. It is
encouraging that the media surrounding vaccination in pregnancy
is dominated by positive messages, yet unfortunately inaccurate
negative articles still persist which criticize the safety and efficacy
of pertussis vaccination. Articles on pertussis vaccination were
more common around the time of its incorporation into routine
Table 3
Response to the question: In your opinion, are the flu and whooping cough vaccines given to pregnant women to primarily protect the mother, the baby, or both equally?
Pertussis Influenza
Mother Baby Both equally Mother Baby Both equally
Pregnant women (N = 300 or 303) 8 (3%) 172 (57%) 123 (41%) 58(19%) 24 (8%) 218 (73%)
Healthcare professionals (N = 199) 4 (2%) 141 (71%) 54 (27%) 101 (51%) 5 (3%) 93 (47%)
Data are N (%).
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influenza and pertussis vaccination seem to evoke similar levels
of media attention. Articles on pertussis vaccination tended to
focus on infant protection and highlight specific examples of recent
cases, whereas influenza articles were more focused on maternal
protection. These themes were similarly reflected in the question-
naire responses, as respondents tended to perceive the pertussis
vaccination as primarily protecting the baby, and the influenza
vaccination as protecting the mother, or the mother and baby
equally. The reported actual, or intended, uptake of pertussis vac-
cination was higher than that of influenza (as has been observed
in nationally [12,11] yet fortunately only a minority of the preg-
nant women surveyed in our study expressed intentions to decline
vaccination against influenza (22%) or pertussis (8%).
Differences between the occurrence of these themes may have
an influence on vaccine uptake. Previous studies indicate that
mothers value protecting their newborn more highly than protect-
ing themselves [17,18], and reading articles on pertussis which
convey a high risk of infection for the baby (especially if associated
with real-life cases of mortality or considered ‘close-to-home’) may
therefore act as a significant facilitator to receive vaccination. In
contrast, the results of this study (as well as previous research
involving patient interviews and focus groups [17,19] demonstrate
that influenza is still portrayed as protecting the mother, and there
may be less incentive to undergo vaccination. Our findings there-
fore provide further support that framing vaccine information
towards the benefits for the child (ideally using specific examples
of real cases) may improve vaccine uptake, in line with recent stud-
ies which demonstrate that information emphasising the protec-
tive benefits for infants is a major motivator for pregnant women
to accept vaccination [20] and improve their health behaviors
[21]. It may also be worth placing an emphasis on the intercon-
nectedness of health interests during pregnancy (particularly for
influenza vaccination) as whilst mothers may not consider them-
selves at risk, it should be highlighted that any decline in their
health could be seriously detrimental for the health of their child.
It is concerning that negative media messages persist with
regards to pertussis vaccination, and that the positive theme of
‘‘vaccine safety” was rarely identified from pertussis articles. The
majority of these negative articles claimed that there was inade-
quate trial evidence to support claims of the vaccine’s safety and
efficacy, despite the growing amount of high-quality evidence from
observational and randomised controlled trials [22–24]. Unfortu-
nately, media articles such as these are likely to have a negative
impact on vaccine uptake, as misperceptions of possible harm
[8,17,25] and inadequate vaccine efficacy and need [26,27] are
commonly cited as the primary reasons for vaccine refusal. It is
hopeful that over time, as the supportive evidence for vaccination
in pregnancy builds, positive media coverage and public confi-
dence will improve.4.1. Implications for clinical practice and research
The media’s portrayal of pertussis vaccination as primarily ben-
efiting the child, using real-life examples, may influence its higher
uptake compared with influenza vaccination, and this approachshould be considered by HCPs when promoting vaccination. Provi-
ders should be aware that vaccine hesitators are most likely to
decline influenza vaccination, and should be prepared to discuss
what is influencing their hesitancy, including specifically address-
ing any negative media that they may have come across. This is
especially important as encouragement from a familiar HCP has
been shown to increase vaccine acceptance by up to 20 times
[8,28]. Successful innovative strategies to educate women and
combat negative media have included the use of social media
and webcasts [29,30], smart phone apps (such as MatImms [31]
and iBooks [30]and mobile phone text messages (such as Tex-
t4baby) [17,32]. Outside traditional media channels (which seem
to generally support vaccination) it is important to be aware of
social media and video-sharing sites which contain large commu-
nities of users critical of vaccination, as gathering information from
these has been associated with lower vaccine uptake [33,34].
Healthcare providers could therefore consider counteracting these
by uploading positive educational material to these forums.
Future qualitative studies should directly assess the relative
influence of media on pregnant women’s vaccine decision making
together with other factors. They should also establish which plat-
forms pregnant women would typically use and trust when gath-
ering information, and consider how their views might be
modified by such information (both positive and negative).
Research conducted over a greater span of time from the vaccine
confidence database would also provide a more comprehensive
overview of the links between vaccine confidence and media
themes, and allow us to better identify trends over time. Future
projects should also assess non-English language media sources,
particularly as previous studies have demonstrated significantly
lower vaccine acceptance amongst ethnic minorities compared to
those identifying as White British [35,36].4.2. Limitations
The major limitations to this study were that the media articles
and questionnaire responses were taken from different time peri-
ods, and the influence of media on the surveyed sample was not
directly assessed. Our search was also limited to the English lan-
guage for ease and accuracy of analysis, yet we appreciate there
may be significant differences amongst non-English language
media sources. By using the LSHTM Vaccine Confidence Database
we were also limited to articles accessible via the Internet, how-
ever we should have captured most media sources given that the
majority have an internet presence. By distributing our question-
naire at four hospitals in southern England, we attempted to max-
imize the demographic diversity of our study population, however
the responses cannot be taken as representative of all pregnant
women and maternity HCPs. Finally, vaccine acceptance was much
higher amongst our questionnaire respondents than national
reports of vaccine uptake, and this may limit the generalisability
of our study findings. All of our respondents were recruited from
antenatal clinics in tertiary hospitals, and therefore it is possible
that our sample was missing subsets of the general population
which could be more -vaccine critical. On the other hand, we relied
upon self-reported vaccination status/intention, and this was not
7630 C.R Wilcox et al. / Vaccine 36 (2018) 7625–7631verified through audit of medical records, meaning that there is
potential reporting bias in our estimations. However recent studies
do suggest that self-reported intention correlates well with actual
uptake [37,38].
4.3. Conclusions
Vaccination uptake amongst pregnant women remains subopti-
mal, yet it is encouraging that the majority of traditional media
channels support pertussis and influenza vaccination in pregnancy.
The media’s portrayal of pertussis vaccination as primarily benefit-
ing the child, using real-life examples, may influence its higher
uptake amongst pregnant women compared with influenza vacci-
nation. We suggest that this approach, as well as the interconnect-
edness of the health of the mother and the health of the baby,
should be emphasised by HCPs when recommending vaccination
to pregnant women. HCPs should be prepared to provide advice
to vaccine hesitators, including specifically addressing any nega-
tive media they may have come across, and consider novel educa-
tional strategies which may help counteract any inaccurate
negative information.
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